William Blair lifts Applied Therapeutics Inc [APLT] price estimate. Who else is bullish?

Applied Therapeutics Inc [NASDAQ: APLT] gained 5.06% on the last trading session, reaching $0.86 price per share at the time.

If compared to the average trading volume of 5.35M shares, APLT reached a trading volume of 5022532 in the most recent trading day, which is why market watchdogs consider the stock to be active.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Here is what top equities market gurus are saying about Applied Therapeutics Inc [APLT]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for APLT shares is $4.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on APLT stock is a recommendation set at 2.17. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

William Blair have made an estimate for Applied Therapeutics Inc shares, keeping their opinion on the stock as Mkt Perform, with their previous recommendation back on December 23, 2024. While these analysts kept the previous recommendation, UBS raised their target price from $13 to $2. The new note on the price target was released on December 02, 2024, representing the official price target for Applied Therapeutics Inc stock. Previously, the target price had yet another drop from $12 to $4, while RBC Capital Mkts kept a Sector Perform rating on APLT stock.

The Average True Range (ATR) for Applied Therapeutics Inc is set at 0.35 The Price to Book ratio for the last quarter was 16.91, with the Price to Cash per share for the same quarter was set at 0.85.

Trading performance analysis for APLT stock

Applied Therapeutics Inc [APLT] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.21. With this latest performance, APLT shares dropped by -57.82% in over the last four-week period, additionally sinking by -80.32% over the last 6 months – not to mention a drop of -74.44% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for APLT stock in for the last two-week period is set at 18.24, with the RSI for the last a single of trading hit 15.72, and the three-weeks RSI is set at 22.21 for Applied Therapeutics Inc [APLT]. The present Moving Average for the last 50 days of trading for this stock 5.6707, while it was recorded at 0.8525 for the last single week of trading, and 5.6811 for the last 200 days.

Applied Therapeutics Inc [APLT]: A deeper dive into fundamental analysis

Applied Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.06 and a Current Ratio set at 1.06.

An analysis of Institutional ownership at Applied Therapeutics Inc [APLT]

There are presently around $106.59%, or 113.15%% of APLT stock, in the hands of institutional investors. The top three institutional holders of APLT stocks are: FRANKLIN RESOURCES INC with ownership of 10.21 million shares, which is approximately 8.1496%. VR ADVISER, LLC, holding 9.54 million shares of the stock with an approximate value of $$44.57 million in APLT stocks shares; and VR ADVISER, LLC, currently with $$37.38 million in APLT stock with ownership which is approximately 6.3877%.